Plasma uric acid and hypertension in a Chinese community: Prospective study and metaanalysis

Clinical Chemistry

Volumn 55, Issue 11, 2009, Pages 2026-2034

  Zhang, Weili ^a   Sun, Kai ^a   Yang, Ying ^b   Zhang, Hongye ^a   Hu, Frank B ^c   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

^b Qingdao Fuwai Hospital   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CHINA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; URIC ACID BLOOD LEVEL; BLOOD; BLOOD PRESSURE; META ANALYSIS; MIDDLE AGED; OBESITY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; BLOOD PRESSURE; CHINA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; URIC ACID;

EID: 70449727922     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.124891     Document Type: Article

References (37)

1. Dollery C, Duncan H, Schumer B. Hyperuricemia related to treatment of hypertension. BMJ 1960;2:832-835
2. Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005;45:18-20. (Pubitemid 40066407)
3. Johnson RJ, Kang DH, Freig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-1190
4. Feig D, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811-1821
5. Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007;18:287-292 (Pubitemid 46053441)
6. Cai Z, Xu X, Wu X, Zhou C, Li D. Hyperuricemia and the metabolic syndrome in Hangzhou. Asia Pac J Clin Nutr 2009;18:81-87
7. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009;61:225-232
8. Zhang YM, Su SS, Muhu YT. Study on the relationship between metabolic syndrome and chronic kidney disease in 1027 patients of Han and Uyguer people. Zhonghua Liu Xing Bing Xue Za Zhi 2008;29:493-496
9. Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 2006;33:1346-1350 (Pubitemid 44025149)
10. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980;93:817-821
11. Cappuccio FP, Strazzulo P, Ferinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling. JAMA 1993;270:354-359
12. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266:3008-3011
13. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004;140:992-1000.
14. Zamboni M, Armellini F, Sheiban I, De Marchi M, Todesco T, Bergamo Andreis IA, et al. Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease. Am J Cardiol 1992;70:1135-1138
15. Crowley LV. Determination of uric acid: an automated analysis based on a carbonate method. Clin Chem 1964;10:838-844
16. Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 2005;45:463-472 (Pubitemid 40341325)
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752
18. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46; erratum, 1998;158:573.
19. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-1686 (Pubitemid 33124327)
20. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986;73:751-754
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72; erratum, 2003;290:197.
23. Kahn HA, Medalie JH, Neufeld HN, Riss E, Goldbourt U. The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J 1972;84:171-182
24. Selby JV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990;131:1017-1027
25. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 2001;19:1209-1215 (Pubitemid 32595276)
26. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523-530 (Pubitemid 36899556)
27. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005;45:28-33. (Pubitemid 40066409)
28. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, et al. Uric acid and the development of hypertension: the Normative Aging Study. Hypertension 2006;48:1031-1036 (Pubitemid 44772704)
29. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991;266:8604-8608
30. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005;16:3553-3562
31. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106:221-226 (Pubitemid 34761303)
32. Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int 2004;66:1465-1470 (Pubitemid 39298378)
33. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005;69:928-933 (Pubitemid 41124260)
34. Hayden MR, Tyagi SC. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond) 2004;1:10.
35. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006;19:1055-1062 (Pubitemid 44485960)
36. Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, et al. Renal function in relation to three candidate genes in a Chinese population. J Mol Med 2004;82:715-722 (Pubitemid 39468496)
37. Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, et al. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens 2004;22:937-944 (Pubitemid 38680468)